TGFβ and matrix-regulated epithelial to mesenchymal transition

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Cancer progression involves genetic and microenvironmental factors that alter tissue architecture.
• Epithelial-mesenchymal transition (EMT) highlights plastic tissue changes and cell-stroma communication.
• The extracellular matrix (ECM) plays a crucial role in cancer biology and EMT.

Purpose of the Study:

• Focuses on the roles of transforming growth factor β (TGFβ) and hyaluronan in cancer biology and EMT.
• Concentrates on breast cancer as a model system.
• Examines the interplay between ECM molecules and cancer progression.

Main Methods:

• Review of existing literature on TGFβ, hyaluronan, and EMT in breast cancer.
• Analysis of signaling pathways and molecular mechanisms involved in EMT.
• Exploration of the role of ECM components in cancer progression.

Main Results:

• Both normal and abnormal TGFβ signaling are present in carcinoma and stromal cells.
• TGFβ-induced EMT necessitates the expression of hyaluronan synthase 2 (HAS2).
• Hyaluronan is a key component of tumor ECM, and elevated levels of hyaluronan and TGFβ may induce a wound-healing response.

Conclusions:

• The link between EMT and metastasis involves mesenchymal-epithelial transition (MET).
• ECM, signaling networks, non-coding RNAs, and epigenetic mechanisms regulate EMT-MET.
• Understanding epithelial plasticity in the mammary gland can lead to breast cancer biomarkers and novel therapeutic approaches.